Enzalutamide alleviates anxiety and depression as well as improves quality of life compared to bicalutamide in metastatic castration-resistant prostate cancer patients: a cohort study

BACKGROUND: This study aimed to evaluate the efficacy of enzalutamide compared with bicalutamide on anxiety, depression and quality of life (QoL) in metastatic castration-resistant prostate cancer (mCRPC) patients. METHODS: Totally 134 mCRPC patients were consecutively enrolled and baseline data wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Feng, Li, Guo-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798785/
https://www.ncbi.nlm.nih.gov/pubmed/35116945
http://dx.doi.org/10.21037/tcr.2019.09.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798785/
https://www.ncbi.nlm.nih.gov/pubmed/35116945
http://dx.doi.org/10.21037/tcr.2019.09.12

Ejemplares similares